Product Information

XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $19.4334 per EA under NDC 50458058451. Its NADAC has been published 593 times since Feb 18, 2015.

The High Outlier badge above means this manufacturer's average price in the Rivaroxaban market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK

Rivaroxaban
$19.4334per EA
High Outlier

NDC

50458058451

Classification

Brand

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022406

On Market Since

9/16/2014

Price Statistics

The NADAC for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK has been published 593 times since Feb 18, 2015, and over the history we have for it it has risen 88.8%. The table below summarizes its recorded NADAC range and movement.

Current price$19.4334 per EA
All-time high$19.5229 (Jun 10, 2026)
All-time low$10.0884 (Mar 18, 2015)
52-week high$19.5229
52-week low$19.0711
Median price$15.1162
Average price$15.1189
Largest weekly change+8.0% (Jan 10, 2018)
Weeks tracked593
Tracking sinceFeb 18, 2015

Price History

1W

0.0%

1M

-0.5%

3M

-0.5%

6M

+1.8%

1Y

+1.8%

3Y

+12.1%

5Y

+23.7%

All

+88.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Rivaroxaban market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?

The current National Average Drug Acquisition Cost (NADAC) for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK, manufactured by Janssen Pharmaceuticals Inc., is $19.4334 per EA (NDC 50458058451), effective Jun 24, 2026.

How has the price of XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK changed over time?

Over the history we have for it, the NADAC for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK has risen 88.8%. It has been tracked across 593 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?

Since Feb 18, 2015, the NADAC for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK has ranged from a low of $10.0884 (Mar 18, 2015) to a high of $19.5229 (Jun 10, 2026), with a median of $15.1162 per EA.

Are there cheaper alternatives to XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK, so no direct lower-cost alternative is listed.

Who manufactures XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?

XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK (NDC 50458058451) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.